Prostate Cancer

Under Review — this page was due to be reviewed by Monday, 05 June 2023. The information shown here may be outdated.

Guidance for referring patients for suspected prostate cancer

Refer to the NCL Cancer Alliance guidance (see Downloads) when referring patients for suspected prostate cancer.

In summary:

  • GPs should continue to refer men with suspected prostate cancer on the current two-week wait (2WW) form
  • GPs should undertake prostate-specific antigen (PSA) testing in symptomatic patients in line with NICE guidelines (new lower urinary tract symptoms, visible haematuria, unexplained non-visible haematuria with dysuria or raised WCC on blood test)
  • GPs should continue to undertake PSA testing in asymptomatic patients following Public Health England’s prostate cancer risk management guidelines
  • GPs should take the opportunity to discuss the need for men to attend secondary care for their investigations and to address/reassure them regarding any concerns they may have
  • NCL ICB is aware that there are pressures on phlebotomy across NCL, but efforts are being made to restore capacity as quickly as possible.

Primary Care Prostate Cancer LCS

For full details of the Primary Care Prostate Cancer Locally Commissioned Service (LCS), visit the LCS page.


Pathways View All

Enhanced Services View All

Review date: Monday, 05 June 2023